We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
-2.74%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$65.5B
AUM Growth
+$10.1B
Cap. Flow
+$12.6B
Cap. Flow %
19.28%
Top 10 Hldgs %
88.32%
Holding
1,088
New
251
Increased
149
Reduced
176
Closed
463

Sector Composition

Rank Sector Weight
1 Technology 0.23%
2 Consumer Discretionary 0.12%
3 Communication Services 0.08%
4 Healthcare 0.01%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRA
376
DELISTED
Coterra Energy
CTRA
$73.8K ﹤0.01%
2,728
-5,997
-69% -$163K
TDS icon
377
PUT
Telephone and Data Systems
TDS
$4.07B
$73.2K ﹤0.01%
+4,000
New +$57.7K
NAT icon
378
CALL
Nordic American Tanker
NAT
$1.33B
$71.7K ﹤0.01%
+17,400
New +$69.5K
SBOW
379
CALL
DELISTED
SilverBow Resources, Inc.
SBOW
$71.5K ﹤0.01%
2,000
TDS icon
380
CALL
Telephone and Data Systems
TDS
$4.07B
$71.4K ﹤0.01%
+3,900
New +$56.3K
ETNB
381
PUT
DELISTED
89bio
ETNB
$71K ﹤0.01%
+4,600
New +$77.2K
TVTX icon
382
Travere Therapeutics
TVTX
$5.21B
$70.4K ﹤0.01%
+7,877
New +$111K
HUT
383
CALL
Hut 8
HUT
$11.4B
$69.8K ﹤0.01%
7,160
+2,040
+40% +$29K
LAZR
384
CALL
DELISTED
Luminar Technologies
LAZR
$69.2K ﹤0.01%
1,013
+120
+13% +$11K
CLS icon
385
CALL
Celestica
CLS
$42.7B
$68.7K ﹤0.01%
+2,800
New +$57.3K
INSM icon
386
Insmed
INSM
$21.4B
$68.6K ﹤0.01%
+2,717
New +$62.1K
CYTK icon
387
Cytokinetics
CYTK
$10.7B
$67.8K ﹤0.01%
+2,302
New +$76.7K
HUYA
388
PUT
Huya Inc
HUYA
$586M
$67.3K ﹤0.01%
+23,700
New +$68.4K
OLK
389
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$66.2K ﹤0.01%
+4,485
New +$75.1K
BITX icon
390
2x Bitcoin ETF
BITX
$894M
$66.1K ﹤0.01%
+6,216
New +$76K
MPT
391
Medical Properties Trust
MPT
$2.78B
$66K ﹤0.01%
12,118
-5,866
-33% -$47K
IHS icon
392
CALL
IHS Holding
IHS
$2.76B
$65.5K ﹤0.01%
+11,800
New +$87.4K
PCT icon
393
PureCycle Technologies
PCT
$1.45B
$64.8K ﹤0.01%
+11,545
New +$108K
ACRS icon
394
PUT
Aclaris Therapeutics
ACRS
$835M
$64.4K ﹤0.01%
9,400
+1,900
+25% +$16.2K
ROIV icon
395
Roivant Sciences
ROIV
$25B
$63.9K ﹤0.01%
+5,472
New +$61.9K
AMAM
396
PUT
DELISTED
Ambrx Biopharma Inc
AMAM
$63.3K ﹤0.01%
5,500
-12,400
-69% -$169K
OCUL icon
397
CALL
Ocular Therapeutix
OCUL
$1.89B
$62.8K ﹤0.01%
20,000
-35,400
-64% -$145K
EVLV icon
398
CALL
Evolv Technologies
EVLV
$1.08B
$62.7K ﹤0.01%
12,900
-300
-2% -$1.85K
MPT
399
PUT
Medical Properties Trust
MPT
$2.78B
$62.1K ﹤0.01%
11,400
+9,800
+613% +$78.5K
NRGV icon
400
PUT
Energy Vault
NRGV
$591M
$61.2K ﹤0.01%
24,000
+500
+2% +$1.5K

Similar funds

Belvedere Trading's Q3 2023 Portfolio in Review

As of Q3 2023, Belvedere Trading held 1,088 positions worth $65.5B, up 18% from $55.5B the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Belvedere Trading deployed $12.6B of net new capital in Q3 2023, opening 251 new positions and adding to 149 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 753,846 shares worth $322M.

By sector, the portfolio is most concentrated in Technology at 0.23% of assets, up from 0.08% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $18.4M trimmed.

  • Belvedere Trading's largest Q3 2023 buy was State Street SPDR S&P 500 ETF Trust: 753,846 shares worth $322M.
  • Belvedere Trading added most to Tesla in Q3 2023, an estimated $75.5M increase.
  • Belvedere Trading's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $18.4M.
  • Belvedere Trading fully exited Amazon in Q3 2023, selling an estimated $137M.
  • Belvedere Trading's ten largest holdings make up 88% of its $65.5B portfolio in Q3 2023.
  • Belvedere Trading opened 251 new positions and closed 463 in Q3 2023.
  • Belvedere Trading's portfolio value rose 18% quarter-over-quarter to $65.5B.

Based on Belvedere Trading's 13F filing for Q3 2023, filed 27 Oct 2023.